Clariane
在场
是其中之一......
Clariane 是一家在股票代码 CLARI (FR) 下上市的公司。
Clariane 在 3 个国家有直接业务。
他们在：
高管
查看带有其 77 名主要高管的组织结构图
Clariane 搜索最多的简介
- Sophie Boissard, Chief Executive Officer and Director
- Jean-Pierre Durpieu, Chairman of the Board
- Florence Barjou, Director
高管在Clariane变化
- Remi Boyer 曾任 Group Chief Human Ressources Officer and Executive Vice President, Germany, 将于 20249月30 升职为 Deputy Chief Executive Office and Chief Executive Officer Germany (新闻发布的2024九月17号).
- Sylvia Metayer已作为Director加入公司 (新闻发布的2024六月12号).
创建提醒
跟踪 Clariane 的高管变动
健康
Clariane 拥有 1,939 家竞争者，其中包括 Siemens Healthineers (德国)、IQVIA (美国(美洲)) 和 Nestlé Health Science (瑞士)。
Popular M&A news in 健康
- Oshi Health 刚刚宣布为 60 筹款数百万美元。 (公布2024十月18号).
- Glooko 刚刚宣布为 100 筹款数百万美元。 (公布2024十月14号).
- Abridge 刚刚宣布为 250 筹款数百万美元。 (公布2024十月14号).
健康 行业的其他推荐联系人
消息
Clariane 的最新新闻稿
- How Clariane is responding to the challenge of mental health care in France and more widely in Europe: Professor Antoine Piau’s viewpoint | Clariane
- ESDW: a selection of climate initiatives in our facilities | Clariane
- Interview with Professor Antoine Piau on how Clariane is redefining care for people living with Alzheimer’s disease | Clariane
- European Sustainable Development Week: Clariane is taking action on climate change! | Clariane
- Non-pharmacological intervention and Alzheimer’s disease | Clariane
- Alzheimer’s disease: our European actions to help our elderly | Clariane
- Clariane announces its entry into the SBF 120 Index | Clariane
- First half 2024 on track – 2024 guidance confirmed | Clariane
- The solidarity fund: a way of supporting our employees facing difficulties | Clariane
- Information on the availability of a second amendment to the 2023 Universal Registration Document | Clariane
- View more press releases Close
关于 Clariane 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Sophie Boissard 
